17 / 21
Page 41
Volume 2
Journal of Molecular Cancer
Cancer & Primary Healthcare 2019
May 20-21, 2019
Cancer Research & Oncology
Primary Healthcare and Medicare Summit
May 20-21, 2019 | Rome, Italy
25
th
Global Meet on
World Congress on
&
Prevalence and associated factors of the incorrect administration of Metered Dose
Inhaler (MDI), dispensing a short-acting bronchodilator by COPD patients in primary
care setting
Saowapha Srisai, Korpchoot Tayakkanonta
Songkhla hospital, Thailand
Background:
Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease characterized by
airflow limitation. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline suggests a
short-acting inhaled bronchodilators and anticholinergic inhaled agents as a first line COPD treatment. In
spite of its popularity, many COPD patients use inhalers incorrectly.
Material and Method:
This is a cross-sectional study. The sample includes patients diagnosed with COPD
who visit Muangsongkhla hospital (N=92) during 1-31 July 2016. The inhaler technique was directly observed
during their visits. Data were analyzed by Program R version 2.13.0.
Results:
92 patients diagnosed with COPD were enrolled in this study. Prevalence of the incorrect
administration of MDI dispensing a short-acting bronchodilator by COPD patients in primary care setting
was 72.8%. Breath-holding for at least 10 seconds after inhalation was found to be the most critical step that
was mistaken. Education was found to be significantly associated with the incorrect administration of MDI
dispensing a short-acting bronchodilator.
Conclusion:
Almost three quarters of COPD patients in primary care setting administer short-acting
bronchodilator incorrectly. The most important factors associated with incorrect inhaler usage of the MDI are
education and income. Therefore, healthcare provider team should carefully provide the instruction for the
methods of using MDI administration to COPD patients and reinforce them periodically asking the patients
to demonstrate how they administer MDI.
cantra_love@yahoo.co.thJ Mol Cancer, Volume 2